KalVista Pharmaceuticals ...

9.97
-1.35 (-11.93%)
At close: Apr 04, 2025, 10:42 AM

KalVista Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Period Ending Apr 30, 2024 Apr 30, 2023 Apr 30, 2022 Apr 30, 2021 Apr 30, 2020 Apr 30, 2019 Apr 30, 2018 Apr 30, 2017 Apr 30, 2016 Apr 30, 2015 Dec 31, 2013 Dec 31, 2012
-126.64M -92.91M -82.34M -46.24M -29.12M -20.82M -15.8M -18.6M -11.44M -7.23M -5.68M -2.05M
816K 718K 564K 537K 512K 378K 180K 40K 33K 38K 27K 38K
21.91M 9.92M 11.09M 7.12M 4.45M 2.97M 1.06M 394K 118K 36K 238K 47K
2.67M 6.31M -14.01M 8.2M -19.64M -20.32M 25.56M -2.58M -584K 617K 145K 43K
-485K 84K 4.88M 114K 13K -103K -651K -1.37M -1.66M 167.00 32K 104K
n/a -491K n/a -42K -33K n/a n/a n/a n/a n/a 63K -6K
15.17M 7.41M -12.32M 8.35M -20.64M -18.79M 25.77M -4.18M -210K 784K 460K 35K
-89.23M -75.26M -78.13M -30.17M -44.82M -36.37M 10.56M -23.72M -13.16M -6.37M -4.86M -1.83M
-443K -1.2M -931K -82K -220K -1.08M -1.43M -74K -11K -125K -18K -91K
n/a -57.86M -57.86M 147.65M -16.75M 69.42M n/a 34.14M n/a n/a n/a n/a
-189.23M -98.25M -136.92M -201.21M -49.8M -79.89M n/a n/a n/a n/a n/a n/a
104.95M 140.86M 195.71M 53.64M 66.77M 11.55M n/a n/a n/a n/a n/a n/a
-443K 57.86M 57.86M -147.65M 16.75M -69.42M -1.43M 34.14M -715K n/a n/a n/a
-84.72M 41.41M 57.86M -147.65M 16.75M -69.42M -1.43M 34.06M -11K -125K -18K -91K
n/a n/a n/a n/a -54K -209K -151K n/a n/a n/a 388K -389K
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
53.77M 1.53M 1.58M 1.53M 216K 242K n/a 2K 33M 8.66M n/a n/a
150.71M 58.12M 1.58M 212.12M 11.58M 87.94M 8.99M 2K 33M 8.66M 6.42M 5.56M
-24.45M 25.51M -19.86M 34.8M -16.22M -19.05M 20.11M 9.19M 19.24M 2.04M 1.54M 3.64M
-89.67M -76.46M -79.06M -30.25M -45.04M -37.45M 9.13M -23.8M -13.17M -6.49M -4.88M -1.93M